Executive Summary

All healthcare providers, including (but not limited to) hospitals, ambulatory/surgical centers, long-term care facilities, physician practices, clinics, and dentistry offices, should be continually assessing their preparedness and identifying available antimicrobial products effective against SARS-CoV-2. The U.S. Centers for Disease Control and Prevention's (CDC) Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic states:

Routine cleaning and disinfection procedures (e.g., using cleaners and water to pre-clean surfaces prior to applying an EPA-registered, hospital-grade disinfectant to frequently touched surfaces or objects for appropriate contact times as indicated on the product's label) are appropriate for SARS-CoV-2 in healthcare settings, including those patient-care areas in which aerosol-generating procedures are performed. Refer to List N on the EPA website for EPA-registered disinfectants . . . for use against SARS-CoV-2.

On March 3, 2020, the U.S. Environmental Protection Agency (EPA) published List N: Disinfectants for Use Against SARS-CoV-2. EPA updated its list on November 5, 2020; the latest update can be found in EPA's List N Tool: COVID-19 Disinfectants. Manufacturers of reusable, noncritical devices and equipment may recommend the use of certain generic disinfectants (e.g., sodium hypochlorite) at certain concentrations. But List N does not specify disinfectant concentrations.

To help you more easily determine whether any products on the list match manufacturer disinfectant recommendations, we've created a table listing the disinfectant concentrations, contact times, and use settings for products in List N. To compile this information, we searched EPA product registrations, amendments, master labels, and other applications. As EPA continues to update the List N Tool, we will update our table as needed.

Who Should Read This

Table of Contents

Overview

All healthcare providers, including (but not limited to) hospitals, ambulatory/surgical centers, long-term care facilities, physician practices, clinics, and dentistry offices, should be continually assessing their preparedness and identifying available antimicrobial products effective against SARS-CoV-2. The U.S. Centers for Disease Control and Prevention's (CDC) Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic states:

Routine cleaning and disinfection procedures (e.g., using cleaners and water to pre-clean surfaces prior to applying an EPA-registered, hospital-grade disinfectant to frequently touched surfaces or objects for appropriate contact times as indicated on the product's label) are appropriate for SARS-CoV-2 in healthcare settings, including those patient-care areas in which aerosol-generating procedures are performed. Refer to List N on the EPA website for EPA-registered disinfectants . . . for use against SARS-CoV-2.

On March 3, 2020, the U.S. Environmental Protection Agency (EPA) published List N: Disinfectants for Use Against SARS-CoV-2. EPA updated its list on November 5, 2020; the latest update can be found in EPA's List N Tool: COVID-19 Disinfectants. Manufacturers of reusable, noncritical devices and equipment may recommend the use of certain generic disinfectants (e.g., sodium hypochlorite) at certain concentrations. But List N does not specify disinfectant concentrations.

To help you more easily determine whether any products on the list match manufacturer disinfectant recommendations, we've created a table listing the disinfectant concentrations, contact times, and use settings for products in List N. To compile this information, we searched EPA product registrations, amendments, master labels, and other applications. As EPA continues to update the List N Tool, we will update our table as needed.
 

Download the Table

Disinfectant Concentrations, Contact Times, and Use Settings for Products Effective against Coronavirus SARS-CoV-2

Glossary

Bibliography

References

Centers for Disease Control and Prevention (CDC), U.S. Interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic [online]. 2020 Nov 4 [cited 2020 Nov 9]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html.

Environmental Protection Agency (EPA), U.S. List N Tool: COVID-19 disinfectants [online]. 2020 Nov 5 [cited 2020 Nov 9]. Available from: https://cfpub.epa.gov/giwiz/disinfectants/index.cfm.

Topics and Metadata

Topics

Biomedical Engineering; Infection Control; Laws, Regulations, Standards; Long-term Care; Procurement Trends; Quality Assurance/Risk Management; Sterilization and Reprocessing; Physician Preference Items; Technology Management; Inventory Management; Service and Maintenance; Technology Selection; Transitions of Care

Caresetting

Ambulatory Care Center; Ambulatory Surgery Center; Assisted-living Facility; Behavioral Health Facility; Dialysis Facility; Emergency Department; Endoscopy Facility; Home Care; Hospice; Hospital Inpatient; Hospital Outpatient; Imaging Center; Independent Living Facility; Physician Practice; Rehabilitation Facility; Short-stay Facility; Skilled-nursing Facility; Substance Abuse Treatment Facility; Trauma Center

Clinical Specialty

Bariatrics; Critical Care; Emergency Medicine; Hospital Medicine; Internal Medicine; Obstetrics; Oncology; Primary Care; Surgery; Transplantation

Roles

Allied Health Personnel; Biomedical/Clinical Engineer; Clinical Practitioner; Environmental Services Manager; Infection Preventionist; Materials Manager/Procurement Manager; Patient Safety Officer; Quality Assurance Manager; Regulator/Policy Maker; Risk Manager

Information Type

Guidance

Phase of Diffusion

 

Technology Class

 

Clinical Category

 

SourceBase Supplier

Product Catalog

MeSH

ICD9/ICD10

FDA SPN

SNOMED

HCPCS

Disease/Condition

 

Publication History